Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Gooseybearon Feb 27, 2020 11:27am

779 Views

Post# 30741203

RE:RE:RE:covid-19 Could Have A Negative Effect On The Ph 2 Trial

Agreed 100% longholder. I'm in bladder cancer NED status and just no more cautious than I was two weeks ago. In an unrelated post, someone mentioned that Coronavirus impacts on the market could negatively impact Trump. It should be clear that one of the most vocal members of the health community in the government scaring people about the Coronavirus is also the sister of Rod Rosenstein who has worked to take down Trump.

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario